Key Details
Price
$26.11Annual ROE
45.26%Beta
0.80Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Biotech and pharmaceutical companies are well known for raising capital through initial public offerings, or IPOs. Between 2001 and 2023, approximately 24% of IPOs were from biotech and pharmaceutical companies.
First-line monotherapy data for once daily firmonertinib selected as an oral presentation in the presidential session
ArriVent BioPharma, Inc., a company focused on advancing innovative biopharmaceutical therapeutics globally, has appointed John Hohneker, M.D. to its Board of Directors. Dr. Hohneker, who has more than three decades of experience in biopharmaceutical leadership and drug development, currently sits on the Boards of public companies Carisma Therapeutics, Inc. and Curis, Inc., as well as private companies Sonata Therapeutics and Trishula Therapeutics.
ArriVent raised $150 million in an upsized IPO, marking one of the strongest performances for a China-linked IPO in New York over the last two years. The company has licensed global rights, excluding Greater China, to furmonertinib, a highly targeted drug used to treat non-small-cell lung cancer.
FAQ
- What is the ticker symbol for ArriVent BioPharma?
- Does ArriVent BioPharma pay dividends?
- What sector is ArriVent BioPharma in?
- What industry is ArriVent BioPharma in?
- What country is ArriVent BioPharma based in?
- When did ArriVent BioPharma go public?
- Is ArriVent BioPharma in the S&P 500?
- Is ArriVent BioPharma in the NASDAQ 100?
- Is ArriVent BioPharma in the Dow Jones?
- When was ArriVent BioPharma's last earnings report?
- When does ArriVent BioPharma report earnings?
- Should I buy ArriVent BioPharma stock now?